RxDoctor Payments Data

Daniel Ryan, MD

Physical Medicine & Rehabilitation · Warren, MINPI 1730195231

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 57 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$346
  • AbbVie$294
  • Sanofi-aventis U.S. LLC$87
  • Teva Pharmaceuticals USA, Inc.$65
  • Amgen$47
  • Collegium Pharmaceutical, Inc.$37
  • plus $184 from 10 others

What the payments were for

  • Food & beverage$1,03998%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 70th percentile of 469 physical medicine & rehabilitation providers in Michigan.

See all physical medicine & rehabilitation providers in Michigan

Medicare billing

Part B allowed, 2024
$298,747
Medicare patients
635
Services billed
5,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxymorphone Hcl ErOxymorphone Hcl35$63,625
Diclofenac Sodium59$25,465
Buprenorphine46$15,427
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen955$15,026
BelbucaBuprenorphine Hcl12$11,137
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen461$10,856
Lidocaine52$6,122
Fentanyl68$5,012
Gabapentin335$3,593
Morphine Sulfate ErMorphine Sulfate135$3,034
Baclofen164$2,900
Oxycodone Hcl122$2,633
Pregabalin189$2,355
XanaxAlprazolam12$2,013
Acetaminophen-CodeineAcetaminophen With Codeine80$1,849

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine$21$15,42746 claims
Collegium Pharmaceutical, Inc.Belbuca$37$11,13712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 469 physical medicine & rehabilitation providers in Michigan.

Other physical medicine & rehabilitation in Warren

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →